Comprehensive Genomic Characterization of 102 Cervical Adenocarcinoma Tumors.

Gejla Toromani, Grace S Saglimbeni, Bhanu Surabi Upadhyayula, Eugene Manu, Tyson J Morris, Beau Hsia, Abubakar Tauseef

Abstract read

In one paragraph

Article in Medicina (Kaunas, Lithuania), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it

0cells of the map it votes in

1citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

Survival-Associated Molecular and Epigenetic Alterations in Endocervical Adenocarcinoma: An Exploratory TCGA Multi-Omics Cohort Study.Current issues in molecular biology · 2026
Article

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Gejla ToromaniCollege of Arts and Science, Miami University, Oxford, OH 45056, USA.ORCID 0009-0009-1186-6428

Grace S SaglimbeniSchool of Medicine, Creighton University, Phoenix, AZ 85012, USA.ORCID 0009-0006-1993-9554

Bhanu Surabi UpadhyayulaSchool of Biological Sciences, University of California, Davis, CA 95616, USA.

Eugene ManuSchool of Natural Sciences and Mathematics, Hofstra University, Hempstead, NY 11549, USA.ORCID 0009-0002-7868-4222

Tyson J MorrisSchool of Medicine, Creighton University, Phoenix, AZ 85012, USA.ORCID 0009-0008-1457-591X

Beau HsiaSchool of Medicine, Creighton University, Phoenix, AZ 85012, USA.ORCID 0009-0009-6403-502X

Abubakar TauseefSchool of Medicine, Creighton University, Omaha, NE 68178, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AdenocarcinomaGenomicsUterine Cervical NeoplasmsAdultAgedClass I Phosphatidylinositol 3-KinasesDNA-Binding ProteinsDNA Copy Number VariationsFemaleHumansMiddle AgedMutationProto-Oncogene Proteins p21(ras)Transcription FactorsTumor Suppressor Protein p53ARID1A protein, humanClass I Phosphatidylinositol 3-KinasesDNA-Binding ProteinsKRAS protein, humanPIK3CA protein, humanProto-Oncogene Proteins p21(ras)TP53 protein, humanTranscription FactorsTumor Suppressor Protein p53cervical adenocarcinomacopy number alterationsgenomic profilingHPV-independent tumorsKRASPIK3CAprecision oncologysomatic mutationsTP53tumor heterogeneity

Identifiers

PMID41597409

DOI10.3390/medicina62010123

PMCPMC12842960

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.